Mahley R W, Hui D Y, Innerarity T L, Weisgraber K H
J Clin Invest. 1981 Nov;68(5):1197-206. doi: 10.1172/jci110365.
We have reported previously that canine livers possess two distinct lipoprotein receptors, an apoprotein (apo)-B,E receptor capable of binding the apo-B-containing low density lipoproteins (LDL) and the apo-E-containing cholesterol-induced high density lipoproteins (HDLc), and an apo-E receptor capable of binding apo-E HDLc but not LDL. Both the apo-B,E and apo-E receptors were found on the liver membranes obtained from immature growing dogs, but only the apo-E receptors were detected on th hepatic membranes of adult dogs. In this study, the expression of the apo-B,E receptors, as determined by canine LDL binding to the hepatic membranes, was found to be highly dependent on the age of the dog and decreased linearly with increasing age. Approximately 30 ng of LDL protein per milligram of membrane protein were bound via the apo-B,E receptors to the hepatic membranes of 7- to 8-wk-old immature dogs as compared with no detectable LDL binding in the hepatic membranes of adult dogs (greater than 1--1.5 yr of age). Results obtained by in vivo turnover studies of canine 125I-LDL correlated with the in vitro findings. In addition to a decrease in the expression of the hepatic apo-B,E receptors with age, these receptors were regulated, i.e., cholesterol feeding suppressed these receptors in immature dogs and prolonged fasting induced their expression in adult dogs. Previously, it was shown that the apo-B,E receptors were induced in adult livers following treatment with the hypocholesterolemic drug cholestyramine. In striking contrast, the apo-E receptors, as determined by apo-E HDLc binding, remained relatively constant for all ages of dogs studied (10--12 ng/mg). Moreover, the expression of the apo-E receptors was not strictly regulated by the metabolic perturbations that regulated the apo-B,E receptors. Similar results concerning the presence of apo-B,E and apo-E receptors were obtained in swine and in man. The hepatic membranes of adult swine bound only apo-E HDLc (apo-E receptors), whereas the membranes from fetal swine livers bound both LDL and apo-E HDLc (apo B,E and apo-E receptors). Furthermore, the membranes from adult human liver revealed the presence of the apo-E receptors as evidenced by the binding of 12--14 ng of HDLc protein per milligram of membrane protein and less than 1 ng of LDL protein per milligram. The membranes from the human liver also bound human chylomicron remnants and a subfraction of human HDL containing apo-E. These data suggest the importance of the E apoprotein and the apo-E receptors in mediating lipoprotein clearance, including chylomicron remnants, by the liver of adult dogs, swine, and man.
我们之前报道过,犬类肝脏拥有两种不同的脂蛋白受体,一种载脂蛋白(apo)-B、E受体,能够结合含apo-B的低密度脂蛋白(LDL)和含apo-E的胆固醇诱导高密度脂蛋白(HDLc),另一种apo-E受体,能够结合apo-E HDLc但不能结合LDL。在未成熟生长犬的肝细胞膜上发现了apo-B、E受体和apo-E受体,但在成年犬的肝细胞膜上仅检测到apo-E受体。在本研究中,通过犬LDL与肝细胞膜的结合来确定apo-B、E受体的表达,发现其高度依赖于犬的年龄,并随年龄增长呈线性下降。每毫克膜蛋白约30纳克的LDL蛋白通过apo-B、E受体与7至8周龄未成熟犬的肝细胞膜结合,而成年犬(大于1至1.5岁)的肝细胞膜中未检测到LDL结合。犬125I-LDL体内周转率研究得到的结果与体外研究结果相关。除了肝apo-B、E受体的表达随年龄下降外,这些受体还受到调节,即喂食胆固醇会抑制未成熟犬的这些受体,而长期禁食会诱导成年犬的这些受体表达。此前,已表明用降胆固醇药物消胆胺治疗后,成年肝脏中会诱导产生apo-B、E受体。与之形成鲜明对比的是,通过apo-E HDLc结合确定的apo-E受体在所有研究年龄的犬中(10至12纳克/毫克)保持相对恒定。此外,apo-E受体的表达不受调节apo-B、E受体的代谢扰动的严格调控。在猪和人类中也获得了关于apo-B、E受体和apo-E受体存在的类似结果。成年猪的肝细胞膜仅结合apo-E HDLc(apo-E受体),而胎儿猪肝细胞膜则结合LDL和apo-E HDLc(apo B、E受体和apo-E受体)。此外,成人肝脏的膜显示存在apo-E受体,每毫克膜蛋白结合12至14纳克HDLc蛋白,每毫克结合不到1纳克LDL蛋白即可证明。人肝脏的膜还结合人乳糜微粒残粒和含apo-E的人HDL亚组分。这些数据表明E载脂蛋白和apo-E受体在介导成年犬、猪和人类肝脏清除脂蛋白(包括乳糜微粒残粒)中的重要性。